What are the causes of elevated Liver Function Tests (LFTs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Elevated liver function tests (LFTs) are most commonly caused by nonalcoholic fatty liver disease (NAFLD) and alcohol-induced liver disease, with other causes including viral hepatitis, medication-induced liver injury, and autoimmune hepatitis. The pattern of LFT elevation can provide diagnostic clues, with hepatocellular patterns (elevated AST/ALT) suggesting direct liver cell damage, and cholestatic patterns (elevated alkaline phosphatase/GGT) indicating bile flow problems 1.

Common Causes of Elevated LFTs

  • Nonalcoholic fatty liver disease (NAFLD)
  • Alcohol-induced liver disease
  • Viral hepatitis (hepatitis A, B, C, D, and E)
  • Medication-induced liver injury
  • Autoimmune hepatitis

Less Common Causes of Elevated LFTs

  • Hemochromatosis
  • Wilson's disease
  • Alpha-1 antitrypsin deficiency
  • Liver malignancies
  • Biliary obstruction

Diagnostic Approach

When evaluating elevated LFTs, it's essential to consider the patient's complete medical history, medication use, alcohol consumption, and risk factors for viral hepatitis 1. Initial workup typically includes:

  • Hepatitis serologies
  • Autoimmune markers
  • Iron studies
  • Imaging of the liver and biliary system The AST:ALT ratio can help differentiate between alcohol-induced and nonalcoholic fatty liver disease, with a ratio >2 suggesting alcohol-induced liver disease and a ratio <1 suggesting nonalcoholic fatty liver disease 1.

From the Research

Causes of Elevated LFTs

Elevated liver function tests (LFTs) can be caused by various factors, including:

  • Viral hepatitis B and C infections, which can lead to liver inflammation and damage 2, 3, 4
  • Non-alcoholic fatty liver disease (NAFLD), a condition characterized by excessive fat accumulation in the liver, which can progress to non-alcoholic steatohepatitis (NASH) and cirrhosis 5, 3, 4
  • Metabolic dysfunction-associated fatty liver disease (MAFLD), a condition associated with insulin resistance, metabolic syndrome, and liver fat accumulation 2
  • Alcoholic liver disease (ALD), which can cause liver inflammation and damage due to excessive alcohol consumption 2
  • Coexistence of multiple liver diseases, such as MAFLD and viral hepatitis, or NAFLD and hepatitis C, which can lead to more severe liver damage and progression to cirrhosis 2, 3, 4

Patterns of Elevated LFTs

The pattern of elevated LFTs can provide clues about the underlying cause of liver damage, including:

  • Hepatocellular pattern (H pattern), characterized by elevated hepatocellular enzymes, which is commonly seen in NAFLD patients 5
  • Cholestatic pattern (C pattern), characterized by elevated cholestatic enzymes, which is associated with advanced fibrosis and metabolic-associated comorbidities in NAFLD patients 5
  • Mixed pattern (M pattern), characterized by a combination of hepatocellular and cholestatic enzymes, which is also seen in NAFLD patients 5

Risk Factors for Elevated LFTs

Certain risk factors can increase the likelihood of developing elevated LFTs, including:

  • Obesity and metabolic syndrome, which are associated with insulin resistance and liver fat accumulation 3, 4
  • Diabetes and hypertension, which are commonly seen in patients with NAFLD and MAFLD 5, 3
  • Family history of liver disease, which can increase the risk of developing viral hepatitis and NAFLD 6
  • Lack of awareness and screening for liver diseases, which can lead to delayed diagnosis and treatment 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Non-alcoholic fatty liver disease and hepatitis C infection.

Minerva gastroenterologica e dietologica, 2006

Research

Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors?

Liver international : official journal of the International Association for the Study of the Liver, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.